Market Tracker

05/25 4:47pm ET

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

89.56
Delayed Data
As of 3:59pm ET
 +1.14 / +1.29%
Today’s Change
75.90
Today|||52-Week Range
143.45
-28.82%
Year-to-Date
Biotech Stock Roundup: XenoPort Soars on Acquisition Deal, AbbVie Crohn's Disease Dru...
3:43pm / Zacks.com - Paid Partner Content
5 Top Biotech Stocks to Buy on Sale
May 17 / MotleyFool.com - Paid Partner Content
A Heavy Hitter Just Stepped Up to the Cystic Fibrosis Plate
May 20 / MotleyFool.com - Paid Partner Content
Nivalis Starts Dosing in Second Phase II Cystic Fibrosis Study
May 17 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Pfizer to Buy Anacor for $5.2B, Pipeline Setbacks for Aduro, T...
May 19 / Zacks.com - Paid Partner Content
Pioneer climbs on oil output optimism
Apr 26 / FT.com - Paid Partner Content
Carlson Reduces Holdings in Monsanto and eBay in st Quarter
May 18 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close88.42
Today’s open88.99
Day’s range88.14 - 89.73
Volume1,598,507
Average volume (3 months)2,436,779
Market cap$21.9B
Dividend yield--
Data as of 3:59pm ET, 05/25/2016

Growth & Valuation

Earnings growth (last year)+26.43%
Earnings growth (this year)+199.74%
Earnings growth (next 5 years)+43.00%
Revenue growth (last year)+77.86%
P/E ratioNM
Price/Sales29.41
Price/Book23.17

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV+0.24+0.57%
ZTSZoetis Inc-0.29-0.61%
INCYIncyte Corp+1.89+2.33%
BMRNBiomarin Pharmaceuti...+0.86+0.98%
Data as of 4:00pm ET, 05/25/2016

Financials

Next reporting dateJuly 25, 2016
EPS forecast (this quarter)$0.22
Annual revenue (last year)$1.0B
Annual profit (last year)-$556.3M
Net profit margin-53.89%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
SVP &
GM-International Commercial Operations
Simon Bedson
Corporate headquarters
Boston, Massachusetts

Forecasts